GlassScriptPhysician profile
Charles N Headrick
NPI 1265537831
$1,505.74
in general payments reported to CMS, 2019-2025
20 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $378 · 2021: $141 · 2022: $146 · 2023: $56.22 · 2024: $182 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $654.81 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.39 | 2019-2021 | |
| Innovation Technologies INC | $135.48 | 2024 | Irrisept |
| Ethicon US, LLC | $71.79 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.15 | 2021-2023 | Gattex |
| Acell, INC. | $52.74 | 2020 | |
| Allergan, INC. | $48.37 | 2020-2022 | |
| Medtronic, INC. | $48.09 | 2025 | Signia |
| Biotissue Holdings INC. | $29.52 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $26.36 | 2022 | |
| Convatec INC. | $25.18 | 2021 | |
| Vioptix INC | $25.04 | 2020 | |
| Innocoll Pharmaceuticals Limited | $25.00 | 2022 | |
| Prescient Surgical | $23.90 | 2020 | |
| Janssen Biotech, INC. | $22.66 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trevena, INC. | $22.50 | 2022 | |
| Thd America, INC. | $21.98 | 2024 | |
| Aroa Biosurgery Incorporated | $21.83 | 2023 | |
| Medspira, LLC | $19.77 | 2022 | |
| Davol INC. | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Headrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.